Kato Pharmaceuticals
Laguna Hills, US
Biotech
Founders & leadership
TS
Terrance S. McGovernExecutive Officer, Director
MB
Mauro B. BoveDirector
OB
Olav B. BergheinDirector
HS
Hugh S. NeuharthExecutive Officer
Reported raises · per SEC filings
Form D private placements$8MraisedOct 2018 · 9 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.